Recent content by r34d1ng

No, it is not. Yes, I would definitely take it even if my tinnitus is not really bothersome (but I fucking hate it).

I don't remember the exact details as it has been 6-7 years. No side effects other than mild to major dizziness for 10-15 minutes here and there. I do remember a major dizziness episode where I briefly passed out; it was definitely scary, but that was it, and I can't really fully blame Trobalt...

Same. Trobalt did not provide any lasting reduction, but it definitely lowered my tinnitus, if not completely shut it down, for some hours.

Based on nothing because I tried Trobalt back in the day when I was already several years into my tinnitus and it worked like a charm.

Frequency Therapeutics Announces Topline Results for its Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss "FX-322-208 Study Fails to Meet Primary Endpoint, Showing No Significant Separation in Speech Perception Between FX-322 and Placebo Company Will Now Focus on...

Someone remind me of the next big date? I believe they are going to publish some important results in Q1 2023?

Anything else to contribute other than an ad hominem fallacy?

Answers below: There are never a "plenty of peer reviewers wanting to peer review." Actually, I don't think nobody would voluntarily peer review a paper. It is a very ungrateful activity where reviewers are not paid, but are imposed extremely tight deadlines and conditions. This is so stupid I...

I don't want to be rude, but as someone who has published papers, I can tell you that you have no idea what you are talking about.

I believe they said during the call that this trial was not enough for the FDA to go straight to market and that they would need to do another one.

Xenon Pharmaceuticals Announces Positive Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101 for the Treatment of Focal Epilepsy Stock +80% as of now.

Frequency Therapeutics Announces New FX-322 Results Showing That Additional Study Participants Gain Hearing Improvements at Later Time Points LEXINGTON, Mass.--(BUSINESS WIRE)--Sep. 22, 2021-- Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage regenerative medicine company focused on...

On a side note, this guy, Risitas, died a few weeks ago, unfortunately.

Still don't get why you all keep wasting so much time and energy with people who only contribute nonsense. Use the Ignore function.

Shots fired :whistle: